Variables | Patient no. (%) | ||
Group Ia (N = 522) | Group IIb (N = 191) | P value | |
Low doses | 363 (69.5) | 15 (7.9) | <0.0001 |
Standard doses | 154 (29.5) | 175 (91.6) | <0.0001 |
High doses | 5 (1.0) | 1 (0.5) |
|
Rifampicin-resistance | 238 (45.6) | 72 (37.7) | 0.0304 |
Successful treatment outcomes | 243 (46.6) | 105 (55.0) | 0.0093 |